Nepal currently relies on 10 pharmacopeia authorized by DDA for standard analytical methods but for non-pharmacopeial drugs (especially combination products) NML develops analytical methods validated by DDA which should be further verified by the manufacturing company. However, pharmacopeial drugs donot require further analytical validation but non-pharmacopeial requires verification by the manufacturing company. Here are list of drugs validated by DDA currently.
| S.No. | Title | Date | Download |
|---|---|---|---|
| 1 | Silodosin Capsules | Jul 23, 2024 |  |
| 2 | Method validation Completed till date | Dec 24, 2019 | |
| 3 | Amlodipine and Ramipril tablet | Dec 24, 2019 | |
| 4 | Folic acid & ferrous ascorbate tablets | Dec 24, 2019 | |
| 5 | Metronidazole & Diloxanide furoate tablets | Dec 24, 2019 | |
| 6 | Metformin SR & Sitagliptin tablets | Dec 24, 2019 | |
| 7 | Cefpodoxime & Potassium Clavulanate for oral suspension | Nov 7, 2019 | |
| 8 | Metformin Immediate & Linagliptin tablets………………………………………………………………._ | Nov 7, 2019 | |
| 9 | Metformin Sustained & Linagliptin tablets…………………………………………………………… | Nov 7, 2019 | |
| 10 | Paracetamol & Chlorzoxazone tablets | Nov 7, 2019 | |
| 11 | sevalamer carbonate tablet | Nov 7, 2019 | |
| 12 | Sodium Valproate and Valproic Acid Tablet………………………………………………………….. | Nov 7, 2019 | |
| 13 | Telmisartan+Chlorthalidone Tablet | Nov 7, 2019 | |
| 14 | Daclatasvir Tablet | Oct 3, 2019 | |
| 15 | Empagliflozin Tablet | Oct 3, 2019 | |
| 16 | Paracetamol & Ibuprofen suspension | Oct 3, 2019 | |
| 17 | Ibandronic Acid Tablets | Oct 3, 2019 | |
| 18 | Aceclofenac SR tablet | Oct 3, 2019 | |
| 19 | Amlodipine and AtorvastatinTablet | Oct 3, 2019 | |
| 20 | Deflazacort Tablet | Oct 3, 2019 | |
| 21 | Esmoprazole fast releasing tablet | Oct 3, 2019 | |
| 22 | Granisetron syrup | Oct 3, 2019 | |
| 23 | Potassium Iodidie, Sodium Chloride, Calcium chloride opthalmic solution | Oct 3, 2019 | |
| 24 | Diacerin tablet | Sep 12, 2019 | |
| 25 | Esomeprazole capsule | Sep 12, 2019 | |
| 26 | Rabeprazole Capsule | Sep 12, 2019 | |
| 27 | Bromhexine HCl & Terbutaline Sulphate Syrup | Sep 12, 2019 | |
| 28 | Clobazam Mouth dissolving Tablet | Sep 12, 2019 | |
| 29 | Dabigatran capsule | Sep 12, 2019 | |
| 30 | Ornidazole Tablet | Sep 12, 2019 | |
| 31 | Sofosbuvir & Ledipasvir Tablet | Sep 12, 2019 | |
| 32 | Tapentadol Tablets | Sep 12, 2019 | |
| 33 | protocol for the guidance and recommendation of document comp | Sep 4, 2019 | |
| 34 | Cefoperazone & Sulbactam injection | Sep 4, 2019 | |
| 35 | Dutasteride Tablet | Sep 4, 2019 | |
| 36 | Granisetron Mouth Dissolving Tablet | Sep 4, 2019 | |
| 37 | Nimesulide Tablet | Sep 4, 2019 | |
| 38 | Tropicamide & Phenylephrine HCl eye drops | Sep 4, 2019 | |
| 39 | Sofosbuvir tablet | Sep 4, 2019 | |
| 40 | Tapentadol capsule | Sep 4, 2019 | |
| 41 | Antacid Suspension with Oxetacaine & Simethicone | Sep 4, 2019 | |
| 42 | Cefdinir Dispersible Tablets | Sep 4, 2019 | |
| 43 | Desloratidine tablets | Sep 4, 2019 | |
| 44 | Febuxostat Tablets | Sep 4, 2019 | |
| 45 | Fexofenadine HCl suspension | Sep 4, 2019 | |
| 46 | Illaprazole tablet | Sep 4, 2019 | |
| 47 | Levocetirizine di HCl syrup | Sep 4, 2019 | |
| 48 | Linagliptine tablet | Sep 4, 2019 | |
| 49 | Rifaximine Tablet | Sep 4, 2019 | |
| 50 | ITOPRIDE sustained release TABLETS | Apr 17, 2019 | |
| 51 | Metformin_sustained release_ & Sitagliptin tablets | Aug 8, 2018 | |
| 52 | Paracetamo & Ibuprofen suspension | Aug 8, 2018 | |
| 53 | Itopride Immediate Release tablet | Aug 8, 2018 | |
- List of ICH Guidelines
- Medicine Registration Guidance Nepal
- Documents Required for New Drug, Industry Registration in Nepal
Discussion about this post